ZD4522

Known as: ZD 4522 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2001
012320012001

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
Rosuvastatin (ZD4522) and pitavastatin (NK-104) are novel HMG-CoA reductase inhibitors with a peculiar pharmacological profile… (More)
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Rosuvastatin (formerly ZD4522) is a new 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (statin) with… (More)
Is this relevant?
Review
2001
Review
2001
Coronary heart disease (CHD) is the leading cause of death worldwide, and effective treatment of hyperlipidaemia can prevent… (More)
Is this relevant?
Review
2001
Review
2001
New approaches to lipid lowering include new uses of proven treatments and development of novel agents. Several large-scale… (More)
Is this relevant?